amylin glp 1 dual agonist receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine GLP-1 and Amylin in the

The results indicate the ability of d-allulose to ameliorate hyperglycemia without risk of hypoglycemic events, suggesting a therapeutic advantage

Pharmacokinetics Agents vary by molecular structure and duration: Short-acting agents (e.g., exenatide twice-daily) primarily influence postprandial glucose

Tirzepatide to retatrutide The tirzepatide to retatrutide transition requires extra caution because retatrutide adds glucagon receptor activation

As congenital syphilis cases continue to increase, same-visit testing and treatment can play an important role in strengthening STI prevention efforts, improving access to care, and helping protect future generations

Adv Ther 40(3):723742 Ghusn W et al (2022) Weight loss outcomes associated with Semaglutide treatment for patients with overweight or obesity

Serious side effects, such as pancreatitis or thyroid issues, are rare